Cost-effectiveness analysis of extended thromboprophylaxis with rivaroxaban versus no prophylaxis in high-risk patients after hospitalisation for COVID-19: an economic modelling st...

por Carvalho de Oliveira, Caroline Cândida, Agati, Leandro Barile, Ribeiro, Camilla Moreira, Resende Aguiar, Valéria Cristina, Caffaro, Roberto Augusto, da Silva Santos, Marisa, Alves Fernandes, Ricardo Ribeiro, Alberto da Silva Magliano, Carlos, Tafur, Alfonso, Spyropoulos, Alex C., Lopes, Renato Delascio, Fareed, Jawed, Ramacciotti, Eduardo
Publicado 2023

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: Venous thromboembolism prophylAxis after gynecoLogical pElvic canc...

por Longo de Oliveira, André Luiz Malavasi, de Oliveira Pereira, Renata Fernanda, Agati, Leandro Barile, Ribeiro, Camilla Moreira, Kawamura Suguiura, Gabrielly Yukimi, Cioni, Claudia Helena, Bermudez, Marilsa, Pirani, Márcia Bermudez, Caffaro, Roberto Augusto, Castelli, Valter, Resende Aguiar, Valéria Cristina, Volpiani, Giuliano Giova, Paschoa, Adilson, Scarlatelli Macedo, Ariane Vieira, de Barros e Silva, Pedro Gabriel Melo, de Campos Guerra, João Carlos, Fareed, Jawed, Lopes, Renato Delascio, Ramacciotti, Eduardo
Publicado 2022